| answer text |
<p>At the start of the COVID-19 pandemic, NHS England and NHS Improvement’s national
commissioning criteria for the use of therapeutic immunoglobulin provided expert guidance
for the management of patients on immunoglobulin treatment. There is a demand management
plan available for use as a contingency to address any instance of constrained supply.</p><p>
</p><p>At present, supplies of immunoglobulin are available for patients who require
it. An updated demand management plan is currently being developed with updated commissioning
criteria to ensure immunoglobulin remains accessible.</p>
|
 |
